Artivion Inc

NYSE: AORT    
Share price (4/26/24): $20.57    
Market cap (4/26/24): $847 million
4 Artivion Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 4 pages Plan of Conversion for Converting Cryolife, Inc., a Florida Corporation to Cryolife, Inc., a Delaware Corporation
12/34/56
EX-2.1
from 8-K 40 pages Asset Purchase Agreement Between Cryolife, Inc. and Baxter Healthcare Corporation Dated as of July 28, 2021
12/34/56
EX-2.1
from 8-K 105 pages Securities Purchase Agreement by and Among Cryolife, Inc., Ascyrus Medical LLC, the Securityholders Listed in Schedule 1 and Fortis Advisors LLC, as the Securityholder Representative Dated as of September 2, 2020
12/34/56
EX-2.1
from 8-K 133 pages  Securities Purchase Agreement by and Among Cryolife, Inc., Cryolife Germany Holdco Gmbh, Jolly Buyer Acquisition Gmbh, Jotec AG, the Securityholders Listed on Schedule 1 Hereto, and Lars Sunnanväder, as the Securityholder Representative
12/34/56
EX-2.1
from 8-K 119 pages Agreement and Plan of Merger by and Among On-X Life Technologies Holdings, Inc., Cryolife, Inc., Cast Acquisition Corporation, Fortis Advisors LLC, Solely in Its Capacity as the Stockholders’ Representative and Each of the Holders Dated as of December 22, 2015
12/34/56
EX-2.1
from 8-K 119 pages Agreement and Plan of Merger by and Among On-X Life Technologies Holdings, Inc., Cryolife, Inc., Cast Acquisition Corporation, Fortis Advisors LLC, Solely in Its Capacity as the Stockholders’ Representative and Each of the Holders Dated as of December 22, 2015
12/34/56
EX-2.1
from 10-Q 68 pages Agreement and Plan of Merger by and Among Cryolife, Inc., CL Crown, Inc., Hemosphere, Inc. and Stockholder Representative Dated as of May 14, 2012 Note: This Agreement and Plan of Merger Is Subject to Revision by the Company at Any Time and Must Be Kept Confidential in Accordance With the Terms of the Confidentiality Agreement Entered Into Between the Recipient of This Agreement and the Company
12/34/56
EX-2.1
from 10-Q 30 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 112 pages Amended and Restated Agreement and Plan of Merger Among Cryolife, Inc., CL Falcon, Inc. and Cardiogenesis Corporation Dated as of April 14, 2011
12/34/56
EX-2.1
from 8-K 83 pages Agreement and Plan of Merger Among Cryolife, Inc., CL Falcon, Inc. and Cardiogenesis Corporation Dated as of March 28, 2011
12/34/56
EX-2.1
from SC TO-C 83 pages Agreement and Plan of Merger Among Cryolife, Inc., CL Falcon, Inc. and Cardiogenesis Corporation Dated as of March 28, 2011
12/34/56
EX-2.4
from 10-K >50 pages Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K ~50 pages Agreement and Plan of Merger
12/34/56
EX-2.2
from 10-Q ~50 pages Asset Purchase Agreement--Ucfi
12/34/56
EX-2.1
from 10-Q ~10 pages Sale Agreement--Ross
12/34/56